Go Pro
→ MILLIONAIRE MASTERCLASS INVITE: Altucher (From Paradigm Press) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
$24.03
+1.6%		$20.99
$16.65
▼
$29.52
$1.02B0.92513,303 shs181,121 shs
Golden Share Resources Co. stock logo
GSH
Golden Share Resources
C$0.05
-10.0%		C$0.04
C$0.04
▼
C$0.17
C$2.17M1.3227,455 shs13,000 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
-1.13%+3.10%+13.06%+21.79%-13.31%
Golden Share Resources Co. stock logo
GSH
Golden Share Resources
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
$24.03
+1.6%		$20.99
$16.65
▼
$29.52
$1.02B0.92513,303 shs181,121 shs
Golden Share Resources Co. stock logo
GSH
Golden Share Resources
C$0.05
-10.0%		C$0.04
C$0.04
▼
C$0.17
C$2.17M1.3227,455 shs13,000 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
-1.13%+3.10%+13.06%+21.79%-13.31%
Golden Share Resources Co. stock logo
GSH
Golden Share Resources
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
1.75
Reduce$22.50-6.35% Downside
Golden Share Resources Co. stock logo
GSH
Golden Share Resources
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest OPG, AMPH, GSH, and ETP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/18/2026
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$20.00 ➝ $23.00
8/7/2026
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$21.00 ➝ $20.00
8/7/2026
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$19.00 ➝ $20.00
7/21/2026
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
7/8/2026
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
6/29/2026
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
Bank of America Corporation logo
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral ➝ Underperform$25.00 ➝ $20.00
6/22/2026
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
(Data available from 9/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
$719.89M1.42$4.27 per share5.62$17.17 per share1.40
Golden Share Resources Co. stock logo
GSH
Golden Share Resources
C$10K216.86C$0.01 per share4.50N/A∞
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
$98.09M$1.6914.229.284.6110.76%14.98%6.96%11/5/2026 (Estimated)
Golden Share Resources Co. stock logo
GSH
Golden Share Resources
N/A-C$0.01N/AN/AN/A-106.97%-490.27%-18.89%N/A

Latest OPG, AMPH, GSH, and ETP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
$0.62$0.91+$0.29$0.67$179.92 million$183.90 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
N/AN/AN/AN/AN/A
Golden Share Resources Co. stock logo
GSH
Golden Share Resources
C$0.511,133.33%N/AN/A N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
0.79
2.40
1.71
Golden Share Resources Co. stock logo
GSH
Golden Share Resources
170.24
0.89
0.83

Institutional Ownership

CompanyInstitutional Ownership
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
65.09%
Golden Share Resources Co. stock logo
GSH
Golden Share Resources
N/A

Insider Ownership

CompanyInsider Ownership
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
29.60%
Golden Share Resources Co. stock logo
GSH
Golden Share Resources
19.72%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
1,97642.54 million29.95 millionOptionable
Golden Share Resources Co. stock logo
GSH
Golden Share Resources
42,58348.19 millionN/ANot Optionable

Recent News About These Companies

Nippon Steel Completes $14.9B U.S. Steel Deal with Golden Share Oversight
June 19, 2025  |  msn.comhttps://www.msn.com/en-us/money/markets/nippon-steel-completes-149b-us-steel-deal-with-golden-share-oversight/vi-AA1GZMXp
Lipari Mining Ltd. (formerly, Golden Share Resources Corporation) Receives Final Approval to ...
March 28, 2025  |  goldseiten.dehttps://www.goldseiten.de/artikel/652279--Lipari-Mining-Ltd.-formerly-Golden-Share-Resources-Corporation-Receives-Final-Approval-to-Commence-Trading-on-Cboe-Canada-on-March-31-2025.html
Lipari Mining Ltd. (Formerly, Golden Share Resources Corporation) Announces Share Consolidation and Name Change
February 4, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/lipari-mining-ltd-formerly-golden-133000772.html
Golden Share Announced Property Purchase Agreement with Delta Resources Limited and Extension of Share Agreement with Lipari Diamond
November 21, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/golden-share-announced-property-purchase-133000286.html
Great Atlantic Resources (TSXV:GR) Intersects Visible Gold in Latest Drilling at Golden Promise Property, Newfoundland
October 31, 2024  |  miningfeeds.comM
Golden opportunity to find out about Golden Share home ownership scheme
October 30, 2024  |  edinburghnews.scotsman.comE
Golden Goliath Sells Mexican Exploration Assets
October 28, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/golden-goliath-sells-mexican-exploration-assets-1033901745
Golden Mile Resources Boosts Pearl Copper Project Funding
October 22, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/golden-mile-resources-boosts-pearl-copper-project-funding-1033867140
Golden Mile Resources Announces New Securities Issue
October 22, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/golden-mile-resources-announces-new-securities-issue-1033867213
Golden Mile Resources Plans Major Securities Issue
October 22, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/golden-mile-resources-plans-major-securities-issue-1033867201
Hesai's Market Share: A Golden Investment Opportunity
October 7, 2024  |  seekingalpha.comhttps://seekingalpha.com/article/4725421-hesai-stock-market-share-creates-golden-investment-opportunity
Golden Triangle Ventures Secures Full Operational Control of its Logistics Assets and Initiates Cash Flow
October 4, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/golden-triangle-ventures-secures-full-operational-control-of-its-logistics-assets-and-initiates-cash-flow-1033821071
Canada announces $151 million for polio eradication, after outbreak in Gaza Strip
September 22, 2024  |  ctvnews.caC
Exploding electronic devices kill 20, wound 450 in second day of explosions in Lebanon
September 19, 2024  |  ctvnews.caC
Golden Crest Education & Service share price
September 14, 2024  |  livemint.comhttps://www.livemint.com/market/market-stats/stocks-golden-crest-education-service-share-price-nse-bse-s0002732
Delta Resources Limited (DTARF)
September 14, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/quote/DTARF/press-releases/
Hi-View’s Golden Stranger Property Returns Gold and Silver Sample Results and Anomalous Gold Zones
August 22, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/hi-view-s-golden-stranger-property-returns-gold-and-silver-sample-results-and-anomalous-gold-zones-1033714630
Golden Chick Honors Franchisee SXThree with Milestone Award
August 3, 2024  |  qsrmagazine.comQ
Golden Energy Group Inks $600 Million Private Loan for Coal Deal
July 22, 2024  |  bloomberg.comhttps://www.bloomberg.com/news/articles/2024-07-22/golden-energy-group-inks-600-million-private-loan-for-coal-deal
Golden Goliath Share Chat
May 28, 2024  |  lse.co.ukhttps://www.lse.co.uk/ShareChat.html?ShareTicker=0UY9

Media Sentiment Over Time

Amphastar Pharmaceuticals stock logo

Amphastar Pharmaceuticals NASDAQ:AMPH

$24.02 +0.39 (+1.63%)
As of 02:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company provides Amphadase, an injection to absorb and disperse other injected drugs; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Golden Share Resources stock logo

Golden Share Resources CVE:GSH

C$0.04 -0.01 (-10.00%)
As of 02/2/2023

Golden Share Resources Corporation engages in the exploration and evaluation of mineral resources in Canada. It primarily explores for gold, base metals, copper, nickel, and diamond deposits. The company holds 100% interests in the Ogoki project comprising ten non-contiguous claim blocks with 30 MLAS mining claims located in the James Bay Lowlands of Ontario; the Kagiami project comprising five small non-contiguous blocks that include 24 MLAS cell claims located in the James Bay Lowlands of Ontario; the Petawanga project comprising one contiguous claim block totalling 4 MLAS cell claims located near north of Lake Nipigon, Northern Ontario; and the Band-Ore project comprising 109 MLAS cell claims, 16 patented claims and 1 Mining lease claim located near west of Thunder Bay, Ontario. It also holds 40% interest in the Pense project comprising 39 claims located in Pense township, Ontario. The company was formerly known as Golden Share Mining Corporation and changed its name to Golden Share Resources Corporation in June 2017. Golden Share Resources Corporation is based in Markham, Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas